<DOC>
	<DOCNO>NCT02412982</DOCNO>
	<brief_summary>This pilot study determine anti-thrombin III ( AT-III ) serum concentration differ patient normal versus subtherapeutic anti-Xa trough concentration place enoxaparin 30 mg twice daily VTE prophylaxis . Secondarily , study compare two enoxaparin dose strategy .</brief_summary>
	<brief_title>Evaluation Venous Thromboembolism Prevention High-Risk Trauma Patients</brief_title>
	<detailed_description>This pilot study determine AT-III serum concentration differ patient normal ( &gt; = 0.1 IU/mL ) versus subtherapeutic ( &lt; 0.1 IU/mL ) anti-Xa trough concentration place enoxaparin 30 mg twice daily venous thromboembolism ( VTE ) prophylaxis . Secondarily , study compare two enoxaparin dose strategy : standard 30 mg twice daily dose strategy base trough anti-Xa value high-risk trauma patient . Specific aim include : 1 ) compare extent reduce AT-III activity patient trough anti-Xa &gt; = 0.1 IU/mL &lt; 0.1 IU/mL upon initial assay ; 2 ) determine proportion patient reach goal anti-Xa time goal anti-Xa achievement two interventional dose strategy : enoxaparin 40 mg every 12 hour ( consideration increase 50 mg every 12 hour recheck anti-Xa goal ) enoxaparin 30 mg every eight hour ; 3 ) compare anti-Xa enoxaparin dose strategy base VTE , bleed rate , transfusion requirement , drug discontinuation rate bioaccumulation , 4 ) determine patient-specific factor correlate subtherapeutic anti-Xa serial AT-III activity , weight , body mass index , age , cumulative fluid administration , thromboelastography ( TEG ) .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>Multisystem trauma Anticipated length stay least 72 hour At high risk ( risk adjustment profile [ RAP ] &gt; = 5 ) initiate enoxaparin 30 mg every 12 hour per VTE prophylaxis protocol No counterindication trauma team VTE prophylaxis protocol ( e.g. , intracranial bleeding , incomplete spinal cord injury hematoma within 24 hour post injury , ongoing hemorrhage , uncorrected coagulopathy , &gt; = grade IV liver spleen injury , intraocular injury ) Renal dysfunction ( creatinine clearance &lt; 30 mL/min continuous renal replacement therapy ) Weight &lt; 50 kg &gt; 150 kg Platelet count &lt; 50,000 Allergy heparin low molecular weight heparin On therapeutic anticoagulation admission require within 24 hour admission Isolated intracranial hemorrhage Known hyperbilirubinemia ( serum bilirubin &gt; 6.6 mg/dL ) Pregnancy Incarceration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>